Prescription Drugs - France

France

Highlights

The Prescription Drugs market in France is anticipated to achieve a revenue of US$42.79bn by 2024.
With a projected annual growth rate (CAGR 2024-2029) of 2.47%, the market volume is expected to reach US$48.35bn by 2029.
When compared globally, United States is projected to generate the highest revenue of US$358.90bn in 2024.
In terms of per person revenues, in France is estimated to generate US$659.60 per individual in 2024.
France's strict regulations on prescription drugs have led to a thriving market for alternative and natural remedies.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Prescription Drugs (Pharmacies) market in France is experiencing significant growth and development.

Customer preferences: Customers in France have a strong preference for prescription drugs, which has led to a steady increase in demand for these products. This is due to the high level of trust that consumers have in prescription drugs, as they are prescribed by healthcare professionals and are seen as more effective and reliable compared to over-the-counter medications. Additionally, customers in France value convenience and accessibility when it comes to purchasing prescription drugs, which has contributed to the growth of the pharmacy market.

Trends in the market: One of the key trends in the Prescription Drugs (Pharmacies) market in France is the increasing use of e-commerce and online platforms for purchasing prescription drugs. This trend has been driven by the convenience and accessibility offered by online pharmacies, as customers can easily order their medications from the comfort of their own homes. Another trend in the market is the growing demand for generic drugs, which are more affordable than brand-name medications. This trend has been influenced by cost-conscious consumers and the efforts of the French government to promote the use of generic drugs to reduce healthcare costs.

Local special circumstances: France has a universal healthcare system, which provides coverage for prescription drugs. This has created a strong demand for these medications, as consumers are able to access them at affordable prices. Additionally, the French government has implemented policies to regulate the pharmacy market and ensure the quality and safety of prescription drugs. These regulations have contributed to the trust that consumers have in the pharmacy sector and have supported the growth of the market.

Underlying macroeconomic factors: The growth of the Prescription Drugs (Pharmacies) market in France can also be attributed to underlying macroeconomic factors. The country has a stable economy and a high level of disposable income, which has allowed consumers to spend more on healthcare and prescription drugs. Furthermore, the aging population in France has increased the demand for prescription drugs, as older individuals tend to have more health conditions that require medication. This demographic trend is expected to continue in the future, further driving the growth of the pharmacy market. In conclusion, the Prescription Drugs (Pharmacies) market in France is experiencing growth and development due to customer preferences for prescription drugs, the increasing use of e-commerce, the demand for generic drugs, the universal healthcare system, government regulations, and underlying macroeconomic factors such as a stable economy and an aging population. These factors are likely to continue driving the growth of the market in the coming years.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.